Robin M Murray, Alessandra Paparelli, Marta Di Forti, Paul Morrison
{"title":"The rising tide of drug-induced psychosis.","authors":"Robin M Murray, Alessandra Paparelli, Marta Di Forti, Paul Morrison","doi":"10.1007/s40211-025-00541-7","DOIUrl":null,"url":null,"abstract":"<p><p>Recreational use of psychotogenic drugs has become more common in the last 30 years with consequent increase in drug-induced psychosis; 25-50% of such psychoses progress to schizophrenia within 5 years. Most cases result from abuse of methamphetamine or cannabis. The spread of methamphetamine psychosis has occurred without any liberalisation of laws; it is highly addictive and easy to make in small \"kitchen\" labs. The increase in cannabis use has been facilitated by a softening of attitudes towards the drug, and in some countries, especially in North America, by legalisation for so-called \"medicinal use\" and then recreational use. The potency of cannabis has greatly increased, especially in countries that have legalised its use, and the worldwide legal sales of cannabis for 2025 are estimated at $ 65 billion. The consequences are being seen with many reports of increases in the incidence of cannabis-psychosis and schizophrenia. In the 1980s some physicians predicted an epidemic of obesity and diabetes due to changes in diet and life style. Sadly, their predictions were correct. We are now at the beginning of a similar epidemic of drug-induced psychosis. Public education campaigns of the type that decreased tobacco smoking are necessary to avoid psychiatric services being overwhelmed.</p>","PeriodicalId":44560,"journal":{"name":"NEUROPSYCHIATRIE","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEUROPSYCHIATRIE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40211-025-00541-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Recreational use of psychotogenic drugs has become more common in the last 30 years with consequent increase in drug-induced psychosis; 25-50% of such psychoses progress to schizophrenia within 5 years. Most cases result from abuse of methamphetamine or cannabis. The spread of methamphetamine psychosis has occurred without any liberalisation of laws; it is highly addictive and easy to make in small "kitchen" labs. The increase in cannabis use has been facilitated by a softening of attitudes towards the drug, and in some countries, especially in North America, by legalisation for so-called "medicinal use" and then recreational use. The potency of cannabis has greatly increased, especially in countries that have legalised its use, and the worldwide legal sales of cannabis for 2025 are estimated at $ 65 billion. The consequences are being seen with many reports of increases in the incidence of cannabis-psychosis and schizophrenia. In the 1980s some physicians predicted an epidemic of obesity and diabetes due to changes in diet and life style. Sadly, their predictions were correct. We are now at the beginning of a similar epidemic of drug-induced psychosis. Public education campaigns of the type that decreased tobacco smoking are necessary to avoid psychiatric services being overwhelmed.
期刊介绍:
Die Zeitschrift ist das offizielle Organ der „Österreichischen Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik (ÖGPP)'', und wissenschaftliches Organ der Österreichischen Alzheimer Gesellschaft, der Österreichischen Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie, der Österreichischen Schizophreniegesellschaft, und der pro mente austria - Österreichischer Dachverband der Vereine und Gesellschaften für psychische und soziale Gesundheit.Sie veröffentlicht Übersichten zu relevanten Themen des Fachs, Originalarbeiten, Kasuistiken sowie Briefe an die Herausgeber. Zudem wird auch Buchbesprechungen sowie Neuigkeiten aus den Bereichen Personalia, Standes- und Berufspolitik sowie Kongressankündigungen Raum gewidmet.Thematisch ist das Fach Psychiatrie und die Methoden der Psychotherapie in allen ihren Facetten vertreten. Die Zeitschrift richtet sich somit an alle Berufsgruppen, die sich mit Ursachen, Erscheinungsformen und Behandlungsmöglichkeiten von psychischen Störungen beschäftigen. -----------------------------------------------------------------------------------------------------· The professional and educational journal of the Austrian Society of Psychiatry, Psychotherapy and Psychosomatics (Österreichische Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik; ÖGPP) and the Austrian Society of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (Österreichische Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie; ÖGKJP)· Overviews of all relevant topics pertaining to the discipline· Intended for all occupational groups committed to the causes and manifestations of, as well as therapy options for psychic disorders· All manuscripts principally pass through a double-blind peer review process involving at least two independent expertsThe official journal of the Austrian Societies of Psychiatry, Psychotherapy and Psychosomatics (ÖGPP) and Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (ÖGKJP)The journal publishes overviews of relevant issues in the field, original work, case reports and letters to the editors. In addition, space is devoted to book reviews, news from the areas of personnel matters and professional policies, and conference announcements.Thematically, the discipline of psychiatry and the methods of psychotherapy are represented in all their facets. The journal is thus aimed at all professional groups committed to the causes and manifestations of, as well as therapy options for psychic disorders